España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Mainz Biomed
MYNZ
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.238700
-0.01
-4.52%
At close: -
$0.240000
0.0013
0.54%
After Hours: 7:58 PM EDT
Get Report
Comment
Mainz Biomed (MYNZ) Forecast
News
Earnings
Mainz Biomed (MYNZ) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Mainz Biomed (NASDAQ:MYNZ) Stock
Mainz Biomed Stock (NASDAQ: MYNZ)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
The Oncology Bet Is Already Paying Off For Pfizer
Upwallstreet
Tuesday, November 12, 2024
Mainz Biomed shares are trading higher after ...
Benzinga Newsdesk
Mainz Biomed Partners With Thermo Fisher Scie...
Benzinga Newsdesk
Monday, October 21, 2024
Mainz Biomed Reported Revenue Of $0.52M For H...
Benzinga Newsdesk
Tuesday, October 15, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, October 14, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Thursday, October 10, 2024
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
Upwallstreet
Tuesday, October 08, 2024
Mainz Biomed Announces Increasing Demand From...
Benzinga Newsdesk
Monday, October 07, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, October 01, 2024
The Covid Era Tech Promises To Reinvent Cancer Treatment
Upwallstreet
Mainz Biomed Publishes CEO Statement; CEO Gui...
Benzinga Newsdesk
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Friday, September 20, 2024
Pfizer Advances On Its Cancer Journey
Upwallstreet
Wednesday, September 04, 2024
Mainz Biomed and Liquid Biosciences Team Up o...
Benzinga Newsdesk
Monday, August 12, 2024
MeiraGTx Holdings PLC Reports Q2 Loss, Lags Revenue Estimates
Zacks
Tuesday, July 30, 2024
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
Upwallstreet
Thursday, July 25, 2024
Mainz Biomed Launches Improvements To ColoAle...
Benzinga Newsdesk
Wednesday, July 10, 2024
Pfizer And Mainz Provide Examples Of Using Emerging Technology For Good
Upwallstreet
Tuesday, July 09, 2024
Mainz Biomed shares are trading higher after ...
Benzinga Newsdesk
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Mainz Biomed Seeks FDA Breakthrough Device De...
Benzinga Newsdesk
Monday, July 08, 2024
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Tuesday, July 02, 2024
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
Upwallstreet
Mainz Biomed Achieves Key Milestones In First...
Benzinga Newsdesk
Wednesday, June 26, 2024
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
Upwallstreet
Tuesday, June 04, 2024
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Upwallstreet
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, June 03, 2024
Mainz Biomed Presents New Study Data For Colo...
Benzinga Newsdesk
Wednesday, May 29, 2024
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, May 28, 2024
Mainz Biomed Presents New Pooled Colorectal C...
Benzinga Newsdesk
Wednesday, May 22, 2024
Global Pharma Giants Are Betting Big On Oncology But Without Daring To Tackle Cancer Prevention
Upwallstreet
Thursday, May 16, 2024
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Upwallstreet
Monday, April 29, 2024
mRNA Is Promising A Breakthrough In Fighting Cancer
Upwallstreet
Thursday, April 25, 2024
Mainz Biomed Reports Topline Results From Poo...
Benzinga Newsdesk
Friday, April 12, 2024
Cantor Fitzgerald Reiterates Neutral on Mainz...
Benzinga Newsdesk
Wednesday, April 10, 2024
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
Upwallstreet
Tuesday, April 02, 2024
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
Upwallstreet
Monday, March 18, 2024
Mainz Biomed To Host Webinar On Early Detection Of Colorectal Cancer,
Happy Mohamed
Tuesday, March 12, 2024
Mainz Biomed Presents ColoAlert At UDH Congress 2024 For Evidence-Based Cancer Screening Innovations
Happy Mohamed
Wednesday, March 06, 2024
HC Wainwright & Co. Maintains Buy on Mainz Bi...
Benzinga Newsdesk
Tuesday, March 05, 2024
Mainz Biomed Partners With Trusted Health Adv...
Benzinga Newsdesk
Wednesday, February 28, 2024
Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
Upwallstreet
Thursday, February 22, 2024
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
Upwallstreet
Mainz Biomed Enters Distribution Partnership ...
Benzinga Newsdesk
Wednesday, February 21, 2024
Mainz Biomed Establishes Strategic Partnershi...
Benzinga Newsdesk
Wednesday, February 07, 2024
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
Upwallstreet
Tuesday, February 06, 2024
Mainz Biomed Announces Opening Of European On...
Benzinga Newsdesk
Thursday, February 01, 2024
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
Upwallstreet
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
Faith Ashmore
-
Sponsored
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
